Same medication, different brand
If you have switched from another tirzepatide product, keeping one continuous log avoids gaps in your history.
Zepbound Tracker App
GLPPal helps you organise tirzepatide injections, appetite, weight and side effects in one tracker built for GLP-1 users.
What follows is compiled from how GLPPal users on Zepbound organise their logs — injection timing, titration notes, and symptom tags — not from manufacturer prescribing information alone. Use it as a tracking reference only; your clinician directs your actual treatment plan.
How to track Zepbound injections
Log each weekly injection on the day you take it — dose strength, date and injection site if you rotate. Add appetite, weight or side effect notes when something changes, especially after a dose increase. GLPPal keeps everything on one timeline so you can review patterns before clinician appointments.
Why tracking improves results on Zepbound
Zepbound shares tirzepatide with other brands but arrives with its own pen formats and regional availability. Users who track from day one — especially those switching from another GLP-1 — keep a continuous history that makes titration and side-effect conversations more concrete.
- A single timeline prevents gaps when moving between tirzepatide products or pen strengths.
- Dose-step logs help users correlate appetite changes with each increase rather than guessing which week things shifted.
- Weight trends viewed alongside injection history reduce overreaction to one-off scale readings.
- Symptom entries with dates give clinicians specific examples instead of vague recollections months later.
Start tracking your GLP-1 journey with GLPPal
Download free on the App Store — injections, appetite, weight and side effects in one calm timeline.
Common Zepbound tracking challenges
Dose step-ups
Each increase is a new chapter. Without records, it is hard to link side effects or appetite shifts to a specific dose.
Multiple metrics to juggle
Injections, weight, appetite and symptoms all matter — but tracking them separately makes the full picture hard to see.
Long-term motivation
After the first few months, logging can slip. A simple, low-friction tracker makes it easier to stay consistent.
What people typically track on Zepbound
Zepbound users often mirror Mounjaro-style logging — same molecule, similar weekly rhythm — but frequently add brand-specific notes about pen type, insurance refill dates, or switching context.
Weekly Zepbound injection
Date, dose (starting at 2.5 mg in many plans), and whether a single-dose vial or KwikPen was used.
Titration schedule
Week each increase occurred, prescriber instructions, and any pause before moving to the next strength.
Food intake patterns
Meal frequency, portion size, and protein intake — many users note these when appetite drops sharply.
Body weight and measurements
Scale weight weekly; some add waist or clothing-fit notes when the scale stalls but fit improves.
GI symptoms
Nausea, bloating, reflux — tagged to hours since injection when possible.
Refill and supply notes
Pharmacy pickup dates and days between pens — practical details users often want before travel.
For symptom-specific logs on Zepbound, try our Zepbound Nausea Tracker, Zepbound Constipation Tracker, and GLP-1 trackers hub — or browse the full hub for every GLP-1 tracker.
Example weekly progress tracking on Zepbound
This two-week snapshot reflects typical GLPPal entries during early Zepbound titration. Individual responses to tirzepatide vary widely — treat this as a formatting example, not a benchmark.
Week 2 — first full week on 2.5 mg
- Sunday: Zepbound 2.5 mg injected; logged first pen lot number for personal records.
- Tuesday: reduced lunch appetite; no nausea.
- Thursday: mild headache — noted possible dehydration after exercise.
- Saturday: weigh-in; compared to baseline recorded at week 0.
Week 4 — approaching 5 mg step-up
- Sunday: final 2.5 mg dose before increase; appetite already lower than week 1.
- Monday: brief nausea after dinner on step-up day; severity mild.
- Wednesday: constipation logged; linked to lower fibre intake.
- Friday: energy stable; appetite suppression consistent through end of week.
Common side effects to monitor on Zepbound
Tirzepatide side effect profiles reported by Zepbound users align closely with other GLP-1/GIP products. Monitor what you actually experience and discuss persistent symptoms with your provider.
Nausea
Frequently logged after dose increases on Zepbound. Users often track whether eating smaller, slower meals changes severity. Track nausea →
Constipation
Common when food volume drops. Bowel frequency logs help distinguish temporary adjustment from ongoing issues. Track constipation →
Fatigue
Some Zepbound users note lower energy in the first month or on injection evenings — worth pairing with sleep and meal logs. Track fatigue →
Headache
Periodic entries, especially when hydration or caffeine intake changes alongside reduced eating. Track headache →
Appetite changes
Often the first thing Zepbound users log — tracking satisfaction at meals, not just hunger levels. Track appetite changes →
How GLPPal helps Zepbound users
- One place for injections, appetite, weight and side effects.
- Clear dose history as you move through titration.
- Quick daily check-ins that take seconds.
- Readable trends without overwhelming charts.
- A supportive tool for your personal GLP-1 journey.
New to Zepbound? Mounjaro Constipation Relief: What to Track and Ways to Manage Symptoms and GLP-1 Cost and Price: What to Track While You Explore Options offer deeper context alongside your tracker.
Frequently asked questions
Both contain tirzepatide, but they are different brand names and may be prescribed for different purposes depending on your region and clinician. GLPPal can track either — log the brand you are using.
Explore more on GLPPal
Medication trackers
Symptom trackers
Track Zepbound with GLPPal
Download on the App Store to log your Zepbound injections, appetite, weight and side effects in one simple app.
GLPPal is designed for tracking and educational purposes only and is not medical advice.